MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    Characterisation and longitudinal significance of subjective cognitive decline in GBA and LRRK2 Parkinson’s disease

    L. Batzu, D. Urso, S. Rota, A. Podlewska, MA. Qamar, KR. Chaudhuri (London, United Kingdom)

    Objective: To investigate the clinical characteristics and predictive value associated with subjective cognitive decline (SCD) in people with Parkinson’s disease (PD) carrying pathogenic GBA or…
  • 2024 International Congress

    Dual Frequency Stimulation of the Subthalamic Nucleus Improves Emotional State in Parkinson’s Disease

    E. Pegolo, F. Cucinotta, I. Hossain, B. Ishihara, M. Hart, E. Pereira, F. Morgante, A. Fasano, L. Ricciardi (Padova, Italy)

    Objective: To evaluate the effect on emotional states of dual frequency STN-DBS (high frequency + low frequency) as compared to high frequency or low frequency…
  • 2024 International Congress

    Shifting Tides of Caffeine: Evaluating Consumption Patterns In Parkinson’s disease Progression

    S. Bouhadoun, S. Zolfaghari, A. Delva, T. Kouchache, A. Pelletier, R. Postuma (Montréal, Canada)

    Objective: This investigation aims to explore temporal shifts in caffeine consumption throughout the Parkinson’s disease (PD) course. Background: Caffeine has been consistently associated with a…
  • 2024 International Congress

    Predicting prodromal Parkinson’s disease with a deep learning algorithm using medical and prescription data

    WW. Lee, Y. Koo, M. Kim (Seoul, Republic of Korea)

    Objective: Our previous study successfully predicted the incidence of Parkinson’s disease (PD) using only diagnostic codes unrelated to motor symptoms during prodromal periods [1]. This…
  • 2024 International Congress

    Unveiling Parkinson’s Disease Risk Factors in the European Population-Based HeBA Cohort

    A. Garrido, C. Horlings, K. Rege, S. Schade, S. Ghosh, P. Mahlknecht, R. Rawal, T. Marques, D. Pilco, C. Gomes, C. Pauly, F. Farfan, D. Mcintyre, K. Seppi, MJ. Marti, C. Trenkwalder, W. Poewe, E. Tolosa, V. Satagopam, R. Krüger, B. Mollenhauer (Barcelona, Spain)

    Objective: Describe the frequency of Parkinson’s disease (PD) risk factors in a European population-based study and analyze the predictive value of online survey single questions…
  • 2024 International Congress

    Behavioral health characteristics of pre-surgical Focused Ultrasound and Deep Brain Stimulation candidates

    D. Kim, S. O'Neill, S. Murthy, A. Waters, C. Palmese (Bronx, USA)

    Objective: To characterize psychological traits in patients who pursue focused ultrasound (FUS) versus deep brain stimulation (DBS) for tremor management Background: Psychosocial characteristics can determine…
  • 2024 International Congress

    Exploring the Root of Cognitive Decline in People Living with Parkinson’s Disease: An Analysis of MoCA Scores, Neuropsychiatric Symptoms, and Patient-Reported Outcomes

    K. Sánchez-Ramírez, S. Arechavala-Lopez, D. Romero-Terán, A. Hernández-Medrano, M. Medina-Pérez, A. Cervantes-Arriaga, M. Rodríguez-Violante (CULIACAN, Mexico)

    Objective: To evaluate cognitive decline in people living with PD (PwP), to determine to which degree different neuropsychiatric symptoms are risk factors for cognitive decline…
  • 2024 International Congress

    Prevalence of Cognitive Disorders and Other Features of Parkinson’s Disease in Kyrgyz Republic

    E. Eralieva, M. Moldokulova, K. Dzholboldieva (Osh, Kyrgyzstan)

    Objective: The aim of the study is to determine the clinical and epidemiological features of PD in low-income countries on the example of Kyrgyzstan. Background:…
  • 2024 International Congress

    Motor and Non-Motor Characteristics of Parkinson’s Disease in a Prevalent Population in Tanzania

    R. Morton, O. Williams, J. Josephat, M. Dekker, W. Howlett, E. Assey, N. Fothergill-Misbah, C. Dotchin, S. Urasa, R. Walker (North Shields, United Kingdom)

    Objective: To determine the features and characteristics of people with Parkinson’s (PwP) identified within a door-to-door prevalence study in Hai District, Tanzania. Background: There is an…
  • 2024 International Congress

    Depression and Cognitive Phenotype in Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Results of a Comparative Study of a New Scale ESDEPARK Assessing Depressive Symptomatology Specifically in IPDWD vs a General Geriatric Depression Scale.

    C A. Hurtado-Gonzalez, S. Ospina-Otalvaro, J F. Ayala-Rico, J M. Márquez, F. Rojas, P A. Gutiérrez-Lenis, K. Rivera, S. Guerrero (Cali, Colombia)

    Objective: To show the Preliminary Results of the ESDEPARK and compare them with a General Geriatric Depression Scale in a sample of patients with IPDWD.…
  • « Previous Page
  • 1
  • …
  • 144
  • 145
  • 146
  • 147
  • 148
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • AI-Powered Detection of Freezing of Gait Using Wearable Sensor Data in Patients with Parkinson’s Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • #28953 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley